BioWorld MedTech

April 15, 2010

Heart valve device makers face hurdles in FDA process

It's no secret that getting a device through the FDA approval process can be time consuming, expensive, and — let's face it — downright difficult. (Medical Device Daily) Read More

Headset allows anesthesiologists to stay focused on the patients

Report from Europe: ConforMIS gets CE mark for new knee replacement system

Washington roundup: GE, Virginia Tech win patent for new CT angio technology

Financings roundup: Articulinx closes on 'B' $10M; Exact prices public offering

Today's MDD food for med-tech thought

Deals roundup: U.S. Renal care to acquire DCA for $112 million in cash

Court report: OrbusNeich claims stent tech misuse by Boston Scientific

Agreements/contracts: Hunt Bioscience to collaborate with Scotland's Tissue Solutions

Med-Tech Notes

Grants roundup: Muve awarded $835K from HHS for its Gruve device

Patent Watch: Interventional Spine gets U.S. patents for PDS system

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...